Literature DB >> 24955072

Neurocysticercosis and epilepsy.

Jorge G Burneo1, Jose E Cavazos2.   

Abstract

Entities:  

Year:  2014        PMID： 24955072      PMCID： PMC3966640          DOI： 10.5698/1535-7511-14.s2.23

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN： 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  6 in total

1.  Predictors of Lesion Calcification in Patients with Solitary Cysticercus Granuloma and New-Onset Seizures.

Authors:  Lalit Mahajan; Hardeep Singh Malhotra; Ravindra Kumar Garg; Neeraj Kumar; Praveen Kumar Sharma; Rajesh Verma; Imran Rizvi
Journal:  Am J Trop Med Hyg       Date:  2016-07-18       Impact factor: 2.345

Review 2.  Acute Symptomatic Seizures and Provoked Seizures: to Treat or Not to Treat?

Authors:  Nisali Gunawardane; Madeline Fields
Journal:  Curr Treat Options Neurol       Date:  2018-08-23       Impact factor: 3.598

Review 3.  Infections of the Central Nervous System in Returning Travelers and Immigrants.

Authors:  Haley Thompson; Kiran Thakur
Journal:  Curr Infect Dis Rep       Date:  2017-10-03       Impact factor: 3.725

4.  Inflammation is a key risk factor for persistent seizures in neurocysticercosis.

Authors:  Jesica A Herrick; Biswajit Maharathi; Jin Suh Kim; Gerardo G Abundis; Anjali Garg; Isidro Gonzales; Herbert Saavedra; Javier A Bustos; Hector H Garcia; Jeffrey A Loeb
Journal:  Ann Clin Transl Neurol       Date:  2018-04-10       Impact factor: 4.511

Review 5.  Unique Characteristics of Epilepsy Development in Neurocysticercosis.

Authors:  Jesica A Herrick; Javier A Bustos; Philip Clapham; Hector H Garcia; Jeffrey A Loeb
Journal:  Am J Trop Med Hyg       Date:  2020-05-14       Impact factor: 2.345

Review 6.  Pathological Targets for Treating Temporal Lobe Epilepsy: Discoveries From Microscale to Macroscale.

Authors:  Jing You; Haiyan Huang; Clement T Y Chan; Lin Li
Journal:  Front Neurol       Date:  2022-01-07       Impact factor: 4.003
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.